Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP)

Q: What does CUSIP 13463J101 represent in this 13F holders report?

CUSIP 13463J101 is the security identifier for CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share in Q2 2025?

28 institutional investors reported CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 13463J101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 51,990,875
Total 13F shares: 11,744,129
Share change: -933,574
Total reported value: $17,029,220
Price per share: $1.45
Number of holders: 28
Value change: -$3,217,598
Number of buys: 12
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 13463J101?
CUSIP 13463J101 identifies CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 13463J101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Top shareholders of CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Enavate Sciences GP, LLC	13F 3/4/5	Company · 10%+ Owner	7.3%	3,785,802	$15,143,208	—	31 Mar 2025	13F 3/4/5
5AM Venture Management, LLC	13F	Company	5.6%	2,927,915	$11,711,660	—	31 Mar 2025	13F
a16z Capital Management, L.L.C.	13F	Company	4.1%	2,125,339	$8,501,356	—	31 Mar 2025	13F
HARBOURVEST PARTNERS LLC	13F	Company	2.4%	1,271,948	$5,087,792	—	31 Mar 2025	13F
FMR LLC	13F	Company	1.5%	766,947	$3,067,788	—	31 Mar 2025	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	635,054	$2,540,216	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.57%	296,216	$1,184,864	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	0.45%	233,833	$935,332	—	31 Mar 2025	13F
Alyeska Investment Group, L.P.	13F	Company	0.38%	200,000	$800,000	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.31%	159,602	$638,408	—	31 Mar 2025	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.16%	81,730	$326,920	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.11%	56,939	$227,756	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.05%	26,236	$104,944	—	31 Mar 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	16,685	$66,740	—	31 Mar 2025	13F
Bank of New York Mellon Corp	13F	Company	0.03%	13,118	$52,472	—	31 Mar 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	11,955	$47,820	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.02%	8,972	$35,888	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	8,243	$32,972	—	31 Mar 2025	13F
BARCLAYS PLC	13F	Company	0.01%	7,508	$30,032	—	31 Mar 2025	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	6,600	$26,400	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	5,820	$23,280	—	31 Mar 2025	13F
CITIGROUP INC	13F	Company	0.01%	5,008	$20,032	—	31 Mar 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	4,643	$18,572	—	31 Mar 2025	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	0.01%	3,786	$15,144	—	31 Mar 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	3,781	$15,124	—	31 Mar 2025	13F
Corebridge Financial, Inc.	13F	Company	0.01%	3,487	$13,948	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	3,264	$13,056	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.01%	3,183	$12,732	—	31 Mar 2025	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	720	$2,880	—	31 Mar 2025	13F
Legal & General Group Plc	13F	Company	0%	708	$2,807	—	31 Mar 2025	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0%	542	$2,168	—	31 Mar 2025	13F
SVB WEALTH LLC	13F	Company	0%	500	$2,000	—	31 Mar 2025	13F
ROYAL BANK OF CANADA	13F	Company	0%	390	$2,000	—	31 Mar 2025	13F
CWM, LLC	13F	Company	0%	260	$1,000	—	31 Mar 2025	13F
AMALGAMATED BANK	13F	Company	0%	235	$1,000	—	31 Mar 2025	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0%	220	$880	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	212	$848	—	31 Mar 2025	13F
Sterling Capital Management LLC	13F	Company	0%	71	$284	—	31 Mar 2025	13F
EverSource Wealth Advisors, LLC	13F	Company	0%	16	$64	—	31 Mar 2025	13F
Northpond Ventures II GP, LLC	3/4/5	10%+ Owner	— class O/S missing	2,238,244	—	—	15 Oct 2024	3/4/5
AH Equity Partners Bio I, L.L.C.	3/4/5	10%+ Owner	— class O/S missing	2,125,339	—	—	15 Oct 2024	3/4/5
Polaris Partners GP X, L.L.C.	3/4/5	10%+ Owner	— class O/S missing	909,090	—	—	15 Oct 2024	3/4/5
Steven H. Holtzman	3/4/5	Director	— mixed-class rows	117,946 mixed-class rows	—	—	25 Jun 2025	3/4/5
David Bumcrot	3/4/5	Chief Scientific Officer	— mixed-class rows	106,741 mixed-class rows	—	—	01 Apr 2025	3/4/5
Michael J. Higgins	3/4/5	Director	— mixed-class rows	37,739 mixed-class rows	—	—	25 Jun 2025	3/4/5
Paula Ragan	3/4/5	Director	— mixed-class rows	29,232 mixed-class rows	—	—	25 Jun 2025	3/4/5
Ravi I. Thadhani	3/4/5	Director	— mixed-class rows	26,014 mixed-class rows	—	—	25 Jun 2025	3/4/5
Douglas E. Williams	3/4/5	Director	— mixed-class rows	20,288 mixed-class rows	—	—	17 Mar 2025	3/4/5
Murray Stewart	3/4/5	Director	— class O/S missing	17,787	—	—	17 Mar 2025	3/4/5
James P. Boylan	3/4/5	Director	— class O/S missing	9,000	—	—	25 Jun 2025	3/4/5

Institutional Holders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) as of Q2 2025

As of 30 Jun 2025, Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,744,129 shares. The largest 10 holders included ENAVATE SCIENCES GP, LLC, 5AM Venture Management, LLC, AH CAPITAL MANAGEMENT, L.L.C., HarbourVest Partners LLC, FMR LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., and VICTORY CAPITAL MANAGEMENT INC. This page lists 28 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

-11

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.